Minireviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. Feb 14, 2023; 29(6): 1054-1075
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.1054
Figure 2
Figure 2 Current immunotherapies for hepatocellular carcinoma. AFP: Alpha-fetoprotein; CAR-T: Chimeric antigen receptors engineered T cell; CTLA4: Cytotoxic T lymphocyte antigen 4; IFN: Interferon-alpha; IL-2: Interleukin-2; NK: Natural killer; PD-1: Programmed cell death-1; PD-L1: Programmed cell death-ligand 1.